U.S. Markets open in 7 hrs 32 mins
  • S&P Futures

    -42.50 (-0.93%)
  • Dow Futures

    -63.00 (-0.18%)
  • Nasdaq Futures

    -301.00 (-1.88%)
  • Russell 2000 Futures

    -49.00 (-2.22%)
  • Crude Oil

    -0.28 (-0.42%)
  • Gold

    +21.40 (+1.22%)
  • Silver

    +0.25 (+1.12%)

    +0.0012 (+0.1019%)
  • 10-Yr Bond

    -0.1050 (-7.25%)
  • Vix

    +2.72 (+9.73%)

    -0.0067 (-0.5029%)

    -0.4090 (-0.3613%)

    -1,453.88 (-2.93%)
  • CMC Crypto 200

    -74.62 (-5.18%)
  • FTSE 100

    -6.89 (-0.10%)
  • Nikkei 225

    +276.20 (+1.00%)

The Zacks Analyst Blog Highlights: Alphabet, Netflix, Thermo Fisher Scientific, Wells Fargo and Novartis

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

For Immediate Release

Chicago, IL – October 22, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alphabet Inc. GOOGL, Netflix, Inc. NFLX, Thermo Fisher Scientific Inc. TMO, Wells Fargo & Co. WFC and Novartis AG NVS.

Here are highlights from Thursday’s Analyst Blog:

Top Stock Reports for Alphabet, Netflix and Thermo Fisher

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet, Netflix and Thermo Fisher Scientific. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Shares of Alphabet have outperformed the S&P 500 in the year to date period (+61.5% vs. +23.1%). The Zacks analyst believes that focus on innovation, strategic acquisitions and a robust Android OS are likely to continue generating strong cash flows for the company.

Alphabet's robust cloud division is also aiding its revenue growth. A deepening focus on the wearables category and growing efforts to gain foothold in the healthcare industry are other major positives. Growing litigation issues, possible escalation in costs, and currency headwinds are some of the major headwinds for Alphabet though.

(You can read the full research report on Alphabet here >>>)

Netflix shares have gained +26.8% over the past six months against the Zacks Broadcast Radio and Television industry’s gain of +6.9%. The Zacks analyst believes that a growing subscriber base, focus on originals across various genres and languages, rapid international expansion and partnerships with telcos are key catalysts for Netflix’s growth.

Solid content slate and resumption of production is expected to aid Netflix’s prospects in the rest of 2021. It is dominating the streaming space on the back of heavy investments in the production and distribution of localized as well as foreign-language content. Stiff competition from major players in the streaming space, a leveraged balance sheet, and high streaming obligation are key concerns for the company though.

(You can read the full research report on Netflix here >>>)

Shares of Thermo Fisher have gained +14.5% over the past three months against the Zacks Medical Instruments industry’s gain of +5.8%. The Zacks analyst believes that the company has been expanding its inorganic growth profile on the back of a spree of takeovers.

Thermo Fisher delivered a strong performance in the second quarter on the back of steady growth in Base business. Robust life sciences space, steady economic activity and strong pandemic response resulted in end market growth in the period. A slowdown in COVID-19 testing demand during the second quarter, foreign currency fluctuations and stiff competition continue to weigh on its margins though.

(You can read the full research report on Thermo Fisher here >>>)

Other noteworthy reports we are featuring today include Wells Fargo and Novartis.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339




Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Wells Fargo & Company (WFC) : Free Stock Analysis Report
Novartis AG (NVS) : Free Stock Analysis Report
Netflix, Inc. (NFLX) : Free Stock Analysis Report
Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report
Alphabet Inc. (GOOGL) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research